JP2021531255A5 - - Google Patents
Info
- Publication number
- JP2021531255A5 JP2021531255A5 JP2021500442A JP2021500442A JP2021531255A5 JP 2021531255 A5 JP2021531255 A5 JP 2021531255A5 JP 2021500442 A JP2021500442 A JP 2021500442A JP 2021500442 A JP2021500442 A JP 2021500442A JP 2021531255 A5 JP2021531255 A5 JP 2021531255A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- monoclonal antibody
- antibody
- seq
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862702143P | 2018-07-23 | 2018-07-23 | |
| US62/702,143 | 2018-07-23 | ||
| PCT/US2019/043108 WO2020023548A1 (en) | 2018-07-23 | 2019-07-23 | Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021531255A JP2021531255A (ja) | 2021-11-18 |
| JPWO2020023548A5 JPWO2020023548A5 (https=) | 2022-08-01 |
| JP2021531255A5 true JP2021531255A5 (https=) | 2022-08-01 |
Family
ID=69181238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500442A Pending JP2021531255A (ja) | 2018-07-23 | 2019-07-23 | 非古典的ｈｌａ−ｉおよびネオアンチゲンを含む複合体を標的とする抗体、およびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210253713A1 (https=) |
| EP (1) | EP3827021A4 (https=) |
| JP (1) | JP2021531255A (https=) |
| AU (1) | AU2019309948A1 (https=) |
| CA (1) | CA3107001A1 (https=) |
| WO (1) | WO2020023548A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1670939B1 (en) | 2003-09-18 | 2009-11-04 | Nuevolution A/S | A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
| US12312412B2 (en) | 2020-05-19 | 2025-05-27 | Amgen Inc. | MAGEB2 binding constructs |
| US11976120B2 (en) | 2020-06-01 | 2024-05-07 | Boehringer Ingelheim International Gmbh | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US10981996B1 (en) * | 2020-06-01 | 2021-04-20 | Abexxa Biologics, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US10981997B1 (en) | 2020-06-01 | 2021-04-20 | Abexxa Biologics, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US20250051454A1 (en) * | 2020-09-15 | 2025-02-13 | Duke University | Antibodies that target hla-e-host peptide complexes and uses thereof |
| CA3229447A1 (en) * | 2021-08-20 | 2023-02-23 | Duke University | Antibodies that target hla-e-host peptide complexes and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1790664A1 (en) * | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| PE20090321A1 (es) * | 2007-06-04 | 2009-04-20 | Genentech Inc | Anticuerpos anti-notch1 nrr, metodo de preparacion y composicion farmaceutica |
| CN105968209B (zh) * | 2011-04-19 | 2021-08-03 | 美国政府(由卫生和人类服务部的部长所代表) | 对磷脂酰肌醇蛋白聚糖3特异的人单克隆抗体及其用途 |
| US10656156B2 (en) * | 2012-07-05 | 2020-05-19 | Mepur Ravindranath | Diagnostic and therapeutic potential of HLA-E monospecific monoclonal IgG antibodies directed against tumor cell surface and soluble HLA-E |
| EP3209687A1 (en) * | 2014-10-23 | 2017-08-30 | Innate Pharma | Treatment of cancers using anti-nkg2a agents |
| MA45491A (fr) * | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés |
| EP3573997A4 (en) * | 2017-01-24 | 2020-12-09 | Abexxa Biologics, Inc. | METHODS AND COMPOSITIONS INTENDED TO TARGE A COMPLEX INCLUDING A NON-CLASSIC HLA-I AND A NEO-ANTIGEN IN THE TREATMENT OF CANCER |
| US11976120B2 (en) * | 2020-06-01 | 2024-05-07 | Boehringer Ingelheim International Gmbh | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US10981996B1 (en) * | 2020-06-01 | 2021-04-20 | Abexxa Biologics, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US10981997B1 (en) * | 2020-06-01 | 2021-04-20 | Abexxa Biologics, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
-
2019
- 2019-07-23 AU AU2019309948A patent/AU2019309948A1/en not_active Abandoned
- 2019-07-23 JP JP2021500442A patent/JP2021531255A/ja active Pending
- 2019-07-23 EP EP19841883.2A patent/EP3827021A4/en not_active Withdrawn
- 2019-07-23 WO PCT/US2019/043108 patent/WO2020023548A1/en not_active Ceased
- 2019-07-23 CA CA3107001A patent/CA3107001A1/en active Pending
- 2019-07-23 US US17/250,443 patent/US20210253713A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531255A5 (https=) | ||
| JP2020514310A5 (https=) | ||
| JP2020502271A5 (https=) | ||
| JP2018035138A5 (https=) | ||
| JP2019536430A5 (https=) | ||
| RU2017105915A (ru) | Антитела против pd-1 | |
| RU2019111722A (ru) | Антитела против siglec-15 и способы их применения | |
| JP2021510736A5 (https=) | ||
| JP2017523786A5 (https=) | ||
| JP2019501883A5 (https=) | ||
| JP2017186337A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2017530722A5 (https=) | ||
| JP2016505546A5 (https=) | ||
| JP2014158469A5 (https=) | ||
| JP2017529838A5 (https=) | ||
| JP2017534577A5 (https=) | ||
| JPWO2019147831A5 (https=) | ||
| CN111278861A (zh) | Pd-l1抗体、其抗原结合片段及医药用途 | |
| JP2020500834A5 (https=) | ||
| JP2025038088A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| JP2021522347A5 (https=) | ||
| JP2013513383A5 (https=) | ||
| JP2017521054A5 (https=) |